Teriparatide相关论文
Introduction: Osteoporotic vertebral factures (OVF) is mostly happened in osteoporotic patients....
Objective:Steroidassociatedosteonecrosisisdifficulttotreat.Teriparatide,astheonlyoneboneanabolicdrug, hasachievedverypro......
Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: a meta-anal
Objectives:osteoporosis remains a clinical challenge.While teriparatide and alendronate represent the anabolic and antir......
Sequential therapy with zoledronic acid and teriparatide for osteoporotic vertebral compression frac
Despite the existence of numerous case series,no evidenced-based medical management for osteoporotic vertebral compressi......
The Clinical Effect of Zoledronic Acid Combined with Teriparatide in Perverting Recurrent Fracture o
<strong>Background:</strong> Zoledronic acid and teriparatide have been proved to be effective in improving bone metabol......
目的 观察不同浓度重组甲状旁腺激素1～34(简称hPTH)对成骨肉瘤细胞系SaOS-2细胞(简称SaOS-2细胞)骨碱性磷酸酶(ALP)和骨钙素(BGP)mR......
目的：观察特立帕肽对老年去卵巢大鼠血管钙化的影响,并探讨其发挥作用的分子机制。方法用30只10个月龄SD大鼠,随机分为3组院假手术......
<正>特立帕肽(teriparatide)即重组人甲状旁腺激素1-34,是一种促骨形成药物,能够调节骨骼合成代谢和分解代谢,低剂量间断给药能有......
目的 探讨甲状旁腺激素(parathyroid hormone,PTH)对大鼠成骨细胞增殖及相关细胞因子的调节作用.方法 将传代的成骨细胞分为对照组......
目的探讨间断性低剂量应用重组人甲状旁腺素（1-34）[recombinant human parathyroid hormone (1-34)，rhPTH （1-34）]在骨折愈合早期对Oste......
目的 比较重组人甲状旁腺激素(rhPTH)(1-34)和依降钙素在治疗绝经后骨质疏松症(OP)妇女中的疗效和安全性.方法 205例绝经后OP妇女,......
目的 观察丝裂素活化蛋白激酶的上游激酶1(MAPKK,MEK1)抑制剂PD98059对大鼠甲状旁腺素1-34(rPTH1-34)诱导的心室肌细胞肥大的影响......
目的探讨绝经老年女性脆性椎体骨折术后应用特立帕肽+钙剂预防椎体再骨折的临床研究。方法选取2015年1月至2017年12月收治的脆性椎......
Effects of Teriparatide and Aerobic Exercise on Lumbar Spine Microstructure in Ovariectomized and Ta
O<span>steoporosis is an increasingly prevalent malady of the elderly that is associated with bone fragility and increas......
Effects of Teriparatide and Aerobic Exercise on Lumbar Spine Microstructure in Ovariectomized and Ta
O<span>steoporosis is an increasingly prevalent malady of the elderly that is associated with bone fragility and increas......
目的：特立帕肽作为促骨形成的代表性药物,具有其独特的作用机制以及确切的增加骨密度、降低椎体骨折风险的疗效。本文介绍特立帕肽......
软骨是一种白色、坚韧且有弹性的组织,它覆盖在关节的表面。在骨关节炎的患者中,软骨由于磨损而变薄,导致关节的疼痛和肿胀。软骨......
目的:探讨特立帕肽联合仙灵骨葆治疗骨质疏松的效果及对患者骨密度水平的影响。方法:选取骨质疏松症患者88例,按照随机数字表法,分......
目的探讨特立帕肽治疗老年绝经后骨质疏松症对患者生活质量的影响,并进行安全性评估。方法将2015年1月至2016年12月于中山大学附属......
目的探讨间断皮下注射人甲状旁腺激素(1~34)[h PTH(1~34)]和[Gly1,Arg19]h PTH(1~34)['G1,R19(1~34)']对大鼠桡骨骨折的影......
目的观察特立帕肽（Teriparatide）治疗原发性骨质疏松症的短期疗效和安全性。方法采用自身前后对照临床研究,纳入2011年12月-2012年12......
目的探索联合使用特立帕肽（PTH）和固力康（KKI）对去势大鼠骨质疏松的防治作用。方法 50只健康雌性SD大鼠随机行假手术（Sham,n=10）和切除双......
BACKGROUND Femoral shaft fractures are a common type of fracture among adults and have high union rates. However, clinic......
Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japan
This randomized prospective study aimed to evaluate the clinical outcome of denosumab treatment alone and in combination......
目的观察特立帕肽对老年去卵巢大鼠血管钙化的影响,并探讨其发挥作用的分子机制。方法用30只10个月龄SD大鼠,随机分为3组：假手术组......
Successful Treatment of Spine Fracture for Diffuse Idiopathic Skeletal Hyperostosis with Teriparatid
We experienced 2 cases of spinal fracture in patients aged 80 years or older with diffuse idiopathic skeletal hyperostos......
We reported a case of atrophic nonunion after humeral shaft fracture in a patient with severe psychiatric disorders that......
随着老龄化社会的到来,低暴力脆性骨折的发病率逐年提高。而锁定钢板和骨水泥加强技术在临床中的应用,使得手术治疗骨质疏松性骨折......
Teriparatide is a recombinant form of the biologically active component of Parathyroid hormone.It has been shown to incr......
Odontoid fractures account for 5%to 15%of all cervical spine injuries and 1%to 2%of all spine fractures.Type II fracture......
Successful Treatment with a Weekly Injection of Teriparatide for the Nonunion of a Distal Humerus Fr
A distal humerus fracture nonunion is one of the complications with which we should be vigilant. It requires an open red......
1商品名Forteo2开发与上市厂商由礼来公司研制开发,2002年12月在美国首次上市....
加拿大健康署批准特立帕肽注射剂（rDNA origin Teriparatide，Forteo）用于治疗有高骨折风险的男性及女性糖皮质激素所致骨质疏松症（GIOP......
